Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1ez0 | NAP | NADP-dependent fatty aldehyde dehydrogenase | 1.2.1.4 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1ez0 | NAP | NADP-dependent fatty aldehyde dehydrogenase | 1.2.1.4 | 1.000 | |
1a4z | NAD | Aldehyde dehydrogenase, mitochondrial | 1.2.1.3 | 0.480 | |
3haz | NAD | Bifunctional protein PutA | / | 0.480 | |
2dsh | SAH | Diphthine synthase | / | 0.475 | |
1xdd | AAY | Integrin alpha-L | / | 0.470 | |
3em0 | CHD | Fatty acid-binding protein 6, ileal (gastrotropin) | / | 0.467 | |
1f4g | TP4 | Thymidylate synthase | / | 0.464 | |
1n4p | CYS_VAL_ILE_LEU_GER | Geranylgeranyl transferase type-1 subunit beta | 2.5.1.59 | 0.458 | |
1f4f | TP3 | Thymidylate synthase | / | 0.457 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.457 | |
1pr0 | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.456 | |
4i8p | NAD | Aminoaldehyde dehydrogenase 1 | / | 0.456 | |
2e7r | SAH | Diphthine synthase | / | 0.454 | |
2ejz | SAH | Diphthine synthase | / | 0.453 | |
1kvk | ATP | Mevalonate kinase | 2.7.1.36 | 0.450 | |
2vb8 | TLM | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.450 | |
2ggs | NDP | dTDP-4-dehydrorhamnose reductase | / | 0.449 | |
2ed3 | SAH | Diphthine synthase | / | 0.448 | |
2j9f | THV | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial | 1.2.4.4 | 0.448 | |
2j9f | THV | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 1.2.4.4 | 0.448 | |
4drj | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.448 | |
4drj | RAP | Peptidyl-prolyl cis-trans isomerase FKBP4 | 5.2.1.8 | 0.448 | |
1dhf | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
4qzu | RTL | Retinol-binding protein 2 | / | 0.446 | |
5eow | FAD | 6-hydroxynicotinate 3-monooxygenase | 1.14.13.114 | 0.446 | |
1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
1ycf | FMN | Nitric oxide reductase | 1 | 0.445 | |
3up4 | FAD | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.445 | |
4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
2dsi | SAH | Diphthine synthase | / | 0.444 | |
4fqs | LYA | Thymidylate synthase ThyA | / | 0.444 | |
1boo | SAH | Modification methylase PvuII | 2.1.1.113 | 0.443 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.443 | |
2ojt | UBA | Glutamate receptor ionotropic, kainate 1 | / | 0.443 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.443 | |
3r5y | F42 | Uncharacterized protein | / | 0.443 | |
4jey | PLP | Acetylornithine/succinyldiaminopimelate aminotransferase | 2.6.1.11 | 0.443 | |
4n3l | 2FN | Prothrombin | 3.4.21.5 | 0.443 | |
4nbb | 9CA | Terminal oxygenase component of carbazole | / | 0.443 | |
1pke | 2FD | Purine nucleoside phosphorylase DeoD-type | / | 0.442 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.442 | |
1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.441 | |
1ja0 | FAD | NADPH--cytochrome P450 reductase | / | 0.441 | |
1uxv | NAP | NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase | / | 0.441 | |
2q2v | NAD | Beta-D-hydroxybutyrate dehydrogenase | / | 0.441 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
4afh | L0B | Achbp | / | 0.441 | |
3vdq | NAD | 3-hydroxybutyrate dehydrogenase | / | 0.440 | |
4iah | 1DX | Alr2278 protein | / | 0.440 |